AUL
EXPO icon

AlphaGrep UK Ltd’s Exponent EXPO Stock Holding History

AlphaGrep UK Ltd’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$309K Buy
+4,739
New +$337K 0.09% 488

Other funds holding EXPO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AlphaGrep UK Ltd's EXPO Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Exponent (EXPO) in Q1 2026: 4,739 shares worth $309K. The stake represents 0.09% of the portfolio and ranks #488 among its holdings.

362 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • AlphaGrep UK Ltd held 4,739 shares of Exponent worth $309K as of Q1 2026.
  • Exponent was a new AlphaGrep UK Ltd position in Q1 2026.
  • Exponent made up 0.09% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #488 holding.
  • 362 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.